GRST · ETHEMA HEALTH Corp
$0.00
At close · Sep 7
View the 10-K filed Jul 1, 2026
Return incl. dividend (before tax)
Going-concern doubt
— flagged Jul 1, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the uncertainties described above, we believe our business plan does not alleviate the existence of substantial doubt about our ability to continue as a going concern within one year from the date of the issuance of these consolidated financial statements.”View the 10-K filed Jul 1, 2026
Customer concentration
— key customers 100% of revenue
Key customers — 100% of revenue (the years ended December 31, 2025 and 2024)
“During the years ended December 31, 2025 and 2024, the Company derived approximately 100% of its in-patient revenues from a group of commercial health care insurers.”
Market Cap
$772,628
Shares
7.73B
Volume · Sep 7
34K
Avg daily vol (10 sessions)
281.25K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.00
Open$0.00
Day$0.00–0.00
52W close$0.00–0.00
Avg vol 30d398K
Short int95K · 0.0% float
Short vol100%
DataJan 2020–Sep 2026
Filing10-K · Jul 1
Up next
filed Jul 1, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$18.76M
Trailing 12 months
Net income (TTM)
−$2.18M
Trailing 12 months
Revenue growth YoY
+228.0%
Year over year
Operating margin
-1.4%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-40.2%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+7.2%
Year over year · more shares
Price change (1Y)
-75.0%
Trailing year
Short interest
0.0%
Latest settlement
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
High
Market backdrop
VIX 17.3 · elevated
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
Death cross
Price vs 200-day avg
−67%
below
Price vs 50-day avg
−50%
below
RSI (14)
37
neutral
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−67%
trailing
6-month return
−67%
trailing
YTD return
−80%
this year
Relative strength
−82%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Death cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Accumulating
+1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1 holders — 13F breadth
Squeeze score
14
low risk · 0–100
Fundamentals
Revenue growth
+212%
Y/Y
Gross margin
25%
contracting
Free cash flow
$-310.6K
Balance sheet
$15.3K
net debt
Quant / Vol
risk profile
Volatility
442%
annualized · 1-yr
Max drawdown
−83%
past year
ATR
0.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
Death cross
Bearish
Price vs 200-day avg
−67%
Bearish
Price vs 50-day avg
−50%
Bearish
RSI (14)
37
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
Death cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Accumulating
+1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1 holders — 13F breadth
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $0
vs 200-day avg -67%
vs 50-day avg -50%
50-day below 200-day death cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GRST
this stock
ETHEMA HEALTH Corp
|
$772,628 | -80.0% | +211.9% | — | 0.0% |
|
HCA
HCA Healthcare, Inc.
|
$103.32B | -0.2% | +7.1% | 15.6 | 2.2% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$28.30B | -12.4% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.45B | +37.0% | +0.9% | 10.3 | 2.3% |
|
EHC
Encompass Health Corp
|
$12.00B | +14.6% | +10.5% | 19.8 | 3.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
1
- % held
- 0.0%
- Net QoQ
- +200.0K sh
- Top holder
- Sterling Investment Advis…
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GRST | +0.0% | -66.7% | -66.7% | +0.0% | -80.0% |
| SPY | +0.1% | -0.4% | +15.1% | +0.4% | +12.9% |
| vs SPY | -0.1% | -66.3% | -81.8% | -0.4% | -92.9% |